ELYM Old Analysis

ELYM Old is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of ELYM Old delisted stock analysis is to determine its intrinsic value, which is an estimate of what ELYM Old is worth, separate from its market price. There are two main types of ELYM Old's stock analysis: fundamental analysis and technical analysis.
The ELYM Old stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. ELYM Old is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. ELYM Stock trading window is adjusted to America/New York timezone.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

ELYM Stock Analysis Notes

About 78.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.99. Some equities with similar Price to Book (P/B) outperform the market in the long run. ELYM Old recorded a loss per share of 2.22. The entity had not issued any dividends in recent years. Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Eliem Therapeutics, Inc. was incorporated in 2018 and is headquartered in Redmond, Washington. Eliem Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people. To learn more about ELYM Old call BAO BCh at 877 354 3689 or check out https://eliemtx.com.

ELYM Old Investment Alerts

ELYM Old is now traded under the symbol CLYM. Please update your portfolios or report it if you believe this is an error. Report It!
ELYM Old is not yet fully synchronised with the market data
ELYM Old has some characteristics of a very speculative penny stock
ELYM Old has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (35.12 M) with profit before overhead, payroll, taxes, and interest of 0.
ELYM Old currently holds about 122.95 M in cash with (20.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.63.
Over 78.0% of the company shares are held by institutions such as insurance companies

ELYM Old Upcoming and Recent Events

4th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

ELYM Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 342.68 M.

ELYM Old Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ELYM Old insiders, such as employees or executives, is commonly permitted as long as it does not rely on ELYM Old's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ELYM Old insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Emily Pimblett over six months ago
Disposition of tradable shares by Emily Pimblett of Eliem Therapeutics at 8.06 subject to Rule 16b-3
 
Valerie Morisset over six months ago
Disposition of 10201 shares by Valerie Morisset of Eliem Therapeutics at 7.09 subject to Rule 16b-3
 
Valerie Morisset over six months ago
Disposition of 30000 shares by Valerie Morisset of Eliem Therapeutics at 7.98 subject to Rule 16b-3
 
Valerie Morisset over six months ago
Disposition of 50000 shares by Valerie Morisset of Eliem Therapeutics at 7.13 subject to Rule 16b-3
 
Valerie Morisset over six months ago
Disposition of 42377 shares by Valerie Morisset of Eliem Therapeutics at 7.01 subject to Rule 16b-3
 
Valerie Morisset over six months ago
Disposition of 50000 shares by Valerie Morisset of Eliem Therapeutics at 7.11 subject to Rule 16b-3
 
Valerie Morisset over six months ago
Disposition of 12342 shares by Valerie Morisset of Eliem Therapeutics at 7.06 subject to Rule 16b-3
 
Ratcliffe Liam over six months ago
Acquisition by Ratcliffe Liam of 10000 shares of Eliem Therapeutics at 7.89 subject to Rule 16b-3
 
Emily Pimblett over six months ago
Disposition of 1245 shares by Emily Pimblett of Eliem Therapeutics at 7.2145 subject to Rule 16b-3
 
Emily Pimblett over six months ago
Acquisition by Emily Pimblett of 5000 shares of Eliem Therapeutics subject to Rule 16b-3
 
Valerie Morisset over six months ago
Acquisition by Valerie Morisset of 255219 shares of Eliem Therapeutics at 0.002 subject to Rule 16b-3
 
Ratcliffe Liam over six months ago
Disposition of tradable shares by Ratcliffe Liam of Eliem Therapeutics subject to Rule 16b-3

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding ELYM Old to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Insider Screener Now

   

Insider Screener

Find insiders across different sectors to evaluate their impact on performance
All  Next Launch Module
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Consideration for investing in ELYM Stock

If you are still planning to invest in ELYM Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ELYM Old's history and understand the potential risks before investing.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings